*001513105
*00520250613173915.0
*007ta
*008110607s1986    xxu           100 u eng d
*00901186cam a2200301 c 4500
*019  $bl
*020  $a0880481412
*035  $a(EXLNZ-47BIBSYS_NETWORK)999821090324702201
*035  $a(NO-LaBS)14702309(bibid)
*035  $a(NO-TrBIB)982109032
*035  $a982109032-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24500$aPsychopharmacology consultation$cedited by David C. Jimerson, John P. Docherty
*260  $aWashington, D.C.$bAmerican Psychiatric Press$cc1986
*300  $aix, 131 s
*4901 $aClinical insights
*500  $aUpdated and expanded version of material presented at a symposium at the annual meeting of the American Psychiatric Association, May 1984.
*650 0$aMental illness$xChemotherapy Congresses$_80148200
*650 0$aPsychopharmacology consultation$xCongresses$_80148300
*650 2$aDrug Therapy$_11066400
*650 2$aMental Disorders$xdrug therapy$_12040000
*650 2$aReferral and Consultation$_15697300
*7001 $aDocherty, John P.$0(NO-TrBIB)98059662$_39772100
*7001 $aJimerson, David C.$0(NO-TrBIB)98059347$_80148400
*7102 $aAmerican Psychiatric Association$bMeeting$0(NO-TrBIB)90410354$cLos Angeles, Calif.)$d1984$n(137th$_34901900
*830 0$aClinical insights$_34902000
*901  $a80
*999  $aoai:nb.bibsys.no:999821090324702202$b2021-11-14T20:26:52Z$z999821090324702202
^